期刊文献+

异黄酮介孔玻璃水泥支架材料修复兔股骨骨缺损

Experimental research of isoflavone-loaded mesoporous glass cement scaffold materials for rabbit-femoral bone defect repair
下载PDF
导出
摘要 目的评价异黄酮介孔玻璃水泥支架材料修复兔股骨骨缺损的效果。方法采用不同组分的骨水泥材料,并用介孔玻璃水泥粉末吸附植物性激素大豆异黄酮(isoflavone,IS),制备成载IS的硫酸钙(calcium sulphate,CS)骨水泥(CS/IS)、载IS的20%介孔硅酸钙镁/硫酸钙(20%mesoporous magnesium calcium silicate/calcium sulfate,20m-MCS/CS)骨水泥(20m-MCS/CS/IS)、载IS的40%介孔硅酸钙镁/硫酸钙(40m-MCS/CS)骨水泥(40m-MCS/CS/IS),检测不同骨水泥支架材料的体外释药性能。将60只成年雄性新西兰大白兔随机分成4组,每组15只,制作右侧股骨末端骨缺损模型后,分别植入CS、20m-MCS/CS、40m-MCS/CS以及40m-MCS/CS/IS,于术后第4、8、12周各组随机处死5只兔并取材,进行micro-CT扫描,脱钙后切片并进行三色染色,普通显微镜下观察。结果 20m-MCS/CS/IS和40m-MCS/CS/IS骨水泥对IS的释放均为缓释,但40m-MCS/CS/IS的释放量更多,在第25天已高达(41.0±1.8)%,因此后续实验中采用40m-MCS/CS/IS。动物实验表明,骨水泥支架植入12周后,CS组的缺损部位仍比较明显,20m-MCS/CS组有了一定程度的修复,40m-MCS/CS组已基本愈合,而40m-MCS/CS/IS组已基本完全愈合并且骨小梁已贯穿骨缺损区。三色染色结果显示40m-MCS/CS/IS复合骨水泥有更快的降解速度,能够促进大量新生骨和成熟骨的产生,其促成骨能力也优于40m-MCS/CS。结论异黄酮介孔玻璃水泥能有效修复腔隙性骨缺损,有望成为新型骨缺损修复材料。 Objective To evaluate the efficacy of isoflavone (IS)-loaded mesoporous glass cement scaffold materials in repairing the rabbit femoral bone defect. Methods Various composite glass cements absorbing plant hormones (soy isoflavone) were fabricated as follows: calcium sulphate (CS), 20% mesoporous magnesium calcium silicate/calcium sulfate (20 m-MCS/ CS), and 40% mesoporous magnesium calcium silicate/calcium sulfate (40 m-MCS/CS). The in vitro isoflavone release profiles of the above materials were evaluated. Sixty New Zealand rabbits were randomized into 4 groups with 15 in each group, and the bone defect models in the distal end of femur were created. Group A: implanted with CS; Group B.. 20 m MCS/CS; Group C: 40 m-MCS/CS; and Group D.. IS-loaded 40 m-MCS/CS (40 m-MCS/CS/IS). The rabbits were sacrificed at 4 weeks, 8 weeks and 12 weeks postoperatively and the bone samples were scanned with micro-CT. Then histology analysis was conducted under microscope after decalcification and Masson trichrome staining. Results Controlled release profiles of isoflavone were presented in both 20 m-MCS/CS/IS and 40 m-MCS/CS/IS groups, and a higher cumulative release rate was detected in 40 m-MCS/CS/IS group, which reached (41.0±1.8)% on the 25th day; therefore 40 m-MCS/CS/IS was selected for further evaluation in vivo, and 40 m-MCS/CS, 20 m-MCS/CS and CS served as controls. Rabbits in Group A implanted with CS showed little new bone formation 12 weeks after operation; those in Group B implanted with 20 m MCS/CS presented with better bone regeneration in the defect site; and the bone defect sites in group C grafted with 40 m-MCS/CS were almost filled with neo-bone; however, the best results were obtained in group D which was implanted with 40 m-MCS/CS/IS, with the defects fully repaired by the bone trabecular. Conclusion Isoflavone-loaded mesoporous glass cement can effectively repair lacunar bone defects, and may serve as a promising new bone regeneration material.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2016年第2期184-190,共7页 Academic Journal of Second Military Medical University
基金 国家自然科学基金国际合作项目(8141101156) 国家自然科学基金(31271031) 上海市科委基础研究重点项目(15411950600) 温州市科技计划项目(Y20130221)~~
关键词 骨代用品 介孔硅酸钙镁 硫酸钙 异黄酮类 骨修复 bone substitutes mesoporous magnesium calcium silicate calcium sulfate isoflavones bone repair
  • 相关文献

参考文献14

  • 1Meagher P J, Morrison W A. Free fibula flap-donor-site morbidity: case report and review of the literature [J]. J Reconstr Microsurg, 2002, 18: 465-468.
  • 2Gu Y D, Cheng D S, Zhang G M, Chen X M, Xu J G, Yang X B. Long-term results of toe transfer.. retrospective analysis [ J ]. J Reconstr Microsurg, 1997, 13.. 405-408.
  • 3Oikarinen J, Korhonen L K. The bone inductive capacity of various bone transplanting materials used for treatment of experimental bone defects [J]. Clin Orthop Relat Res, 1979, 140.. 208-215.
  • 4Vitale D C, Piazza C, Melilli B, Drago F, Salomone S. Isoflavones: estrogenic activity, biological effect and bioavailability[J]. Eur J Drug Metab Pharmacokinet, 2013, 38.. 15 25.
  • 5Singh S P, Wahajuddin, All M M, Jain G K. High- throughput quantification of isoflavones, biochanin A and genistein, and their conjugates in female rat plasma using LC-ESI-MS/MS: application in pharmacokinetic study[J]. ] Sep Sci, 2010, 33: 3326-3334.
  • 6Jeon B J, Ahn J, Kwak H S. Effect of isoflavone- enriched milk on bone mass inovarieetomized rats[J]. J Med Food, 2009, 12.. 1260-1267.
  • 7D' Adamo C R, Sahin A. Soy foods and supplementation., a review of commonly perceived health benefits and risks[J]. Altern Ther Health Med, 2014, 20(Suppl 1).. 39-51.
  • 8Schneider P, Hudec P, Solcova O. Pore-volume and surface area in microporous-mesoporous solids [J].Micropor Mesopor Mater, 2008, 115.. 491-496.
  • 9Vallet-Regi M, Balas F, Arcos D. Mesoporous materials for drug delivery[J]. Angew Chem Int Ed Engl, 2007, 46.. 7548-7558.
  • 10vander Pol U, Mathieu L, Zeiter S, Bourban P E, Zambelli P Y, Pearee S G, et al. Augmentation of bone defect healing using a new biocomposite scaffold.. an in vivo study in sheep[J]. Acta Biomater, 2010, 6: 3755-3762.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部